High- and Low-Dose Oral Delayed-Release Mesalamine in Children With Mild-to-Moderately Active Ulcerative Colitis

OBJECTIVE: The aim of the study was to assess the safety and efficacy of high- and low-dose oral, delayed-release mesalamine in a randomized, double-blind, active control study of children with mild-to-moderately active ulcerative colitis. METHODS: Patients ages 5 to 17 years, with a Pediatric Ulcer...

Descripción completa

Detalles Bibliográficos
Autores principales: Winter, Harland S., Krzeski, Piotr, Heyman, Melvin B., Ibarguen-Secchia, Eduardo, Iwanczak, Barbara, Kaczmarski, Maciej, Kierkus, Jaroslaw, Kolaček, Sanja, Osuntokun, Bankole, Quiros, J. Antonio, Shah, Manoj, Yacyshyn, Bruce, Dunnmon, Preston M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2014
Materias:
Original Articles: Gastroenterology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255757/
https://www.ncbi.nlm.nih.gov/pubmed/25419597
http://dx.doi.org/10.1097/MPG.0000000000000530

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255757/
https://www.ncbi.nlm.nih.gov/pubmed/25419597
http://dx.doi.org/10.1097/MPG.0000000000000530

Ejemplares similares